pJC2747 - pET28-SKP1(A2P, ∆38-43, ∆71-82)-FBXO31(∆1-65, D334N)
(Plasmid
#250278)
-
PurposeRecombinant production of SKP1(A2P, ∆38-43, ∆71-82) and 6His-Smt3-StrepII-FBXO31(∆1-65, D334N).
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 250278 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepET28
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameSKP1
-
SpeciesH. sapiens (human)
-
MutationA2P, ∆38-43, ∆71-82
-
Entrez GeneSKP1 (a.k.a. EMC19, OCP-II, OCP2, SKP1A, TCEB1L, p19A)
- Promoter T7
Cloning Information for Gene/Insert 1
- Cloning method Unknown
- 5′ sequencing primer n/a
- (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert nameFBXO31
-
SpeciesH. sapiens (human)
-
Mutation∆1-65, D334N
-
Entrez GeneFBXO31 (a.k.a. FBX14, FBXO14, Fbx31, MRT45, pp2386)
- Promoter T7
-
Tag
/ Fusion Protein
- 6xHis-Smt3(SUMO)-StrepII (N terminal on insert)
Cloning Information for Gene/Insert 2
- Cloning method Unknown
- 5′ sequencing primer n/a
- (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pJC2747 - pET28-SKP1(A2P, ∆38-43, ∆71-82)-FBXO31(∆1-65, D334N) was a gift from Jacob Corn (Addgene plasmid # 250278 ; http://n2t.net/addgene:250278 ; RRID:Addgene_250278) -
For your References section:
C-terminal amides mark proteins for degradation via SCF-FBXO31. Muhar MF, Farnung J, Cernakova M, Hofmann R, Henneberg LT, Pfleiderer MM, Denoth-Lippuner A, Kalcic F, Nievergelt AS, Peters Al-Bayati M, Sidiropoulos ND, Beier V, Mann M, Jessberger S, Jinek M, Schulman BA, Bode JW, Corn JE. Nature. 2025 Feb;638(8050):519-527. doi: 10.1038/s41586-024-08475-w. 10.1038/s41586-024-08475-w PubMed 39880951